Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Treatment of Extracranial Carotid Artery Disease With the ENROUTE™ Transcarotid Neuroprotection System (ENTRUST)

NCT07455747 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT07455747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07455747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Treatment of Extracranial Carotid Artery Disease With the ENROUTE™ Transcarotid Neuroprotection System (ENTRUST)
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Recruiting
Start date
August 19, 2026
Completion date
April 30, 2030
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

extracranial carotid artery disease, tcar, transcarotid artery revascularization